Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shock

CONCLUSION: In this exploratory study of patients with CS treated with MCS, the timing of device implantation within 24 h after CS onset was not associated with mortality. This supports a restrictive MCS approach, reserving its application for patients experiencing CS deterioration despite conventional …